Latest debt-to-equity ratio
Lyell Immunopharma Debt-to-equity ratio
Direct answer
Lyell Immunopharma's debt-to-equity ratio is 19.93%.
The verified market snapshot reports 19.93%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Lyell Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 19.93%
Explore related company data
View Lyell Immunopharma's market capitalizationView Lyell Immunopharma's price-to-book ratioView Lyell Immunopharma's return on equityView Lyell Immunopharma's dividend yieldView Lyell Immunopharma's 52-week price rangeView Lyell Immunopharma's revenue growthView Lyell Immunopharma's profit marginView all Lyell Immunopharma key metricsReturn to Lyell Immunopharma profile